S K Carter. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Amines/therapeutic useAnimalsAntineoplastic Agents/therapeutic useAzacitidine/therapeutic useBleomycin/therapeutic useCarcinoma, Bronchogenic/drug therapyCarmustine/therapeutic useCyclic P-Oxides/therapeutic useCyclophosphamide/therapeutic useDimethylamines/therapeutic useDoxorubicin/therapeutic useEthylamines/therapeutic useEvaluation Studies as TopicHumansKetones/therapeutic useLung Neoplasms/drug therapyNeoplasms, Experimental/drug therapyNitrosourea Compounds/therapeutic useOrganophosphorus Compounds/therapeutic useOxazines/therapeutic usePiperazines/therapeutic usePlatinum/therapeutic useTriazines/therapeutic use
Substances： See more » AminesAntineoplastic AgentsCyclic P-OxidesDimethylaminesEthylaminesKetonesNitrosourea CompoundsOrganophosphorus CompoundsOxazinesPiperazinesTriazinesBleomycinPlatinumDoxorubicinCyclophosphamideAzacitidineCarmustine
Year: 1972 PMID： 4117256 DOI： 10.1002/1097-0142(197211)30:5<1402::aid-cncr2820300539>3.0.co;2-n
Source DB: PubMed Journal: Cancer ISSN： 0008-543X Impact factor: 6.860